Trial Profile
Phase II study: 2-chlorodeoxyadenosine [cladribine] and cytarabine in idiopathic hypereosinophilic syndrome.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Cladribine (Primary) ; Cytarabine (Primary)
- Indications Leukaemia
- Focus Therapeutic Use
- 27 Apr 2010 Actual end date (July 2008) added as reported by ClinicalTrials.gov.
- 27 Apr 2010 Actual patient number (13) added as reported by ClinicalTrials.gov.
- 27 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.